Searched for
MOLBIO DIAGNOSTICS TARGET PRICE
Neuberg Diagnostics consolidates its Maharashtra operations with NM MedicalNeuberg Diagnostics has consolidated its operations with NM Medical in Maharashtra to enhance diagnostic and preventive healthcare. This pa...- Bitcoin price target: Why Citi raised its BTC USD forecast to $113,000 from $82,000 as the cryptocurrency reboundsBitcoin (BTC USD) price target: Citigroup has increased its 12-month Bitcoin price target from $82,000 to $113,000 due to favorable market ...
- Motilal Oswal initiates coverage on Molbio Diagnostics stock with Buy, sees 21% upside. Here's whyMotilal Oswal initiated coverage on Molbio Diagnostics with a Buy rating and ₹1,800 target, implying 21% upside. The brokerage sees strong ...
- Lord’s Mark strengthens UK and UK allied market strategy with regulatory backing for IVD portfolio.In an exciting development, Lord's Mark Industries has secured registration for its In-Vitro Diagnostic portfolio with the MHRA, significan...
- Trent shares hit 10% upper circuit after Q2 revenue rises 23% YoY to Rs 5,788 crore. Should you buy, sell or hold?Tata Group retail arm Trent reported a 23% year-on-year surge in Q2FY27 standalone revenue to Rs 5,788 crore, supported by strong growth ac...
- Nvidia still 'the one' for AI? BNP Paribas raises target to $345, sees up to 47% upsideBNP Paribas has retained its Outperform rating on Nvidia and raised its target price to $345 from $285, implying 47% upside. The brokerage ...
- Nomura sees IndiGo emerging stronger from fuel shock; initiates Buy with Rs 6,000 targetNomura initiated coverage on InterGlobe Aviation with a Buy rating and a Rs 6,000 target price, implying around 20% upside from the Septemb...
- AMFI reshuffle: NSE may get largecap status, SBI Fund Management may become midcap in H1 CY27Nuvama expects NSE to enter the largecap category and SBI Funds Management to become a midcap in AMFI’s H1 CY27 reshuffle. Bosch, Siemens E...
- Coal India, NTPC among 360 ONE Capital’s 8 stock picks for October. Check full list with target prices360 ONE Capital Research has picked eight stocks for October, including Coal India, NTPC and ITC, with Buy ratings and target prices, citin...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- PB Fintech shares crash 50% from peak, fall below 2021 IPO price. More downside coming?PB Fintech shares plunged 50% from their all-time high to drop below the 2021 IPO price of Rs 980. The sharp six-day selloff follows propos...
- TBO Tek shares gain 3%; Nuvama initiates 'Buy' with Rs 2,200 targetShares of travel tech firm TBO Tek rose nearly 3% on Thursday to Rs 1,733 after brokerage Nuvama initiated coverage with a Buy rating and a...
- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
- Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerag...
- Goldman Sachs sees Eternal achieving $1 billion EBITDA by FY29; raises target priceGoldman Sachs maintained a Buy rating on Eternal, formerly Zomato, raising its target price by 11% to Rs 385. The brokerage foresees Eterna...
- NSE shares fall 2%, slip below IPO price, but analysts’ target prices go up to Rs 2,050. Time to buy?NSE slipped below their Rs 1,785 IPO price on Monday, taking its market capitalisation to Rs 4.36 lakh crore. Despite the decline, brokerag...
- Clean energy ambition needs grid stability milestones: ReportIndia’s 500 GW non-fossil capacity target for 2030 needs to be backed by clear grid-stability milestones, a Ficci-Nangia report said. It re...
- India needs five-year policy to make precision cancer care afforable, says expertIndia needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr ...
- Stocks to buy: Macquarie initiates Outperform rating on these 4 capital market stocks. Do you own any?Macquarie sees a strong multiyear growth outlook for India’s capital market industry, driven by rising financialisation of savings. It expe...
- Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The ...
Load More
